Literature DB >> 17579806

Identification of seven novel cryptic exons embedded in the dystrophin gene and characterization of 14 cryptic dystrophin exons.

Zhujun Zhang1, Yasuaki Habara1, Atsushi Nishiyama1, Yoshinobu Oyazato1, Mariko Yagi1, Yasuhiro Takeshima1, Masafumi Matsuo2.   

Abstract

The dystrophin gene, which is mutated in Duchenne and Becker muscular dystrophy, is characterized by its extremely large introns. Seven cryptic exons from the intronic sequences of the dystrophin gene have been shown to be inserted into the processed mRNA. In this study, we have cloned seven novel cryptic exons embedded in dystrophin introns that were amplified from dystrophin mRNA isolated from lymphocytes. All of these sequences, which ranged in size from 27 to 151 bp, were found to be cryptic exons because they were completely homologous to intronic sequences (introns 1, 18, 29, 63, 67, and 77), and possessed consensus sequences for branch points, splice acceptor sites, and splice donor sites. Compared with the 77 authentic dystrophin exons, the 14 cryptic exons were characterized by (1) lower Shapiro's splicing probability scores for the splice donor and acceptor sites; (2) smaller and larger densities of splicing enhancer and silencer motifs, respectively; (3) a longer distance between the putative branch site and the splice acceptor site; and (4) with one exception, the introduction of premature stop codons into their respective transcripts. These characteristics indicated that the cryptic exons were weaker than the authentic exons. Our results suggested that a mutation deep within an intron that changed these parameters could cause dystrophinopathy. The cryptic exons identified provide areas that should be examined for the detection of mutations in the dystrophin gene, and they may help us to understand the roles of large dystrophin introns.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17579806     DOI: 10.1007/s10038-007-0163-0

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  61 in total

1.  Multiple splicing defects in an intronic false exon.

Authors:  H Sun; L A Chasin
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  Minimal conditions for exonization of intronic sequences: 5' splice site formation in alu exons.

Authors:  Rotem Sorek; Galit Lev-Maor; Mika Reznik; Tal Dagan; Frida Belinky; Dan Graur; Gil Ast
Journal:  Mol Cell       Date:  2004-04-23       Impact factor: 17.970

3.  Sequence conservation, relative isoform frequencies, and nonsense-mediated decay in evolutionarily conserved alternative splicing.

Authors:  Daehyun Baek; Phil Green
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-25       Impact factor: 11.205

4.  Fewer genes, more noncoding RNA.

Authors:  Jean-Michel Claverie
Journal:  Science       Date:  2005-09-02       Impact factor: 47.728

5.  Alternative splicing in the alpha-galactosidase A gene: increased exon inclusion results in the Fabry cardiac phenotype.

Authors:  Satoshi Ishii; Shoichiro Nakao; Reiko Minamikawa-Tachino; Robert J Desnick; Jian-Qiang Fan
Journal:  Am J Hum Genet       Date:  2002-02-04       Impact factor: 11.025

6.  Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy.

Authors:  S B Malhotra; K A Hart; H J Klamut; N S Thomas; S E Bodrug; A H Burghes; M Bobrow; P S Harper; M W Thompson; P N Ray
Journal:  Science       Date:  1988-11-04       Impact factor: 47.728

7.  Dystrophin gene analysis on 130 patients with Duchenne muscular dystrophy with a special reference to muscle mRNA analysis.

Authors:  M Ikezawa; N Minami; M Takahashi; Y Goto; T Miike; I Nonaka
Journal:  Brain Dev       Date:  1998-04       Impact factor: 1.961

8.  Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

Authors:  M Koenig; E P Hoffman; C J Bertelson; A P Monaco; C Feener; L M Kunkel
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

9.  Two alternative exons can result from activation of the cryptic splice acceptor site deep within intron 2 of the dystrophin gene in a patient with as yet asymptomatic dystrophinopathy.

Authors:  Mariko Yagi; Yasuhiro Takeshima; Hiroko Wada; Hajime Nakamura; Masafumi Matsuo
Journal:  Hum Genet       Date:  2002-10-31       Impact factor: 4.132

10.  Nonclassical splicing mutations in the coding and noncoding regions of the ATM Gene: maximum entropy estimates of splice junction strengths.

Authors:  Laura Eng; Gabriela Coutinho; Shareef Nahas; Gene Yeo; Robert Tanouye; Mahnoush Babaei; Thilo Dörk; Christopher Burge; Richard A Gatti
Journal:  Hum Mutat       Date:  2004-01       Impact factor: 4.878

View more
  13 in total

1.  Tissue- and case-specific retention of intron 40 in mature dystrophin mRNA.

Authors:  Atsushi Nishida; Maki Minegishi; Atsuko Takeuchi; Emma Tabe Eko Niba; Hiroyuki Awano; Tomoko Lee; Kazumoto Iijima; Yasuhiro Takeshima; Masafumi Matsuo
Journal:  J Hum Genet       Date:  2015-04-02       Impact factor: 3.172

2.  Alternative splicing, activation of cryptic exons and amino acid substitutions in carotenoid biosynthetic genes are associated with lutein accumulation in wheat endosperm.

Authors:  Crispin A Howitt; Colin R Cavanagh; Andrew F Bowerman; Christopher Cazzonelli; Lynette Rampling; Joanna L Mimica; Barry J Pogson
Journal:  Funct Integr Genomics       Date:  2009-03-28       Impact factor: 3.410

3.  Neuronal SH-SY5Y cells use the C-dystrophin promoter coupled with exon 78 skipping and display multiple patterns of alternative splicing including two intronic insertion events.

Authors:  Atsushi Nishida; Maki Minegishi; Atsuko Takeuchi; Hiroyuki Awano; Emma Tabe Eko Niba; Masafumi Matsuo
Journal:  Hum Genet       Date:  2015-07-08       Impact factor: 4.132

4.  HEK293 cells express dystrophin Dp71 with nucleus-specific localization of Dp71ab.

Authors:  Atsushi Nishida; Sato Yasuno; Atsuko Takeuchi; Hiroyuki Awano; Tomoko Lee; Emma Tabe Eko Niba; Takahiro Fujimoto; Kyoko Itoh; Yasuhiro Takeshima; Hisahide Nishio; Masafumi Matsuo
Journal:  Histochem Cell Biol       Date:  2016-04-25       Impact factor: 4.304

Review 5.  Normal and altered pre-mRNA processing in the DMD gene.

Authors:  Sylvie Tuffery-Giraud; Julie Miro; Michel Koenig; Mireille Claustres
Journal:  Hum Genet       Date:  2017-06-09       Impact factor: 4.132

6.  Cryptic splice activation but not exon skipping is observed in minigene assays of dystrophin c.9361+1G>A mutation identified by NGS.

Authors:  Emma Tabe Eko Niba; Atsushi Nishida; Van Khanh Tran; Dung Chi Vu; Masaaki Matsumoto; Hiroyuki Awano; Tomoko Lee; Yasuhiro Takeshima; Hisahide Nishio; Masafumi Matsuo
Journal:  J Hum Genet       Date:  2017-01-19       Impact factor: 3.172

7.  Whole dystrophin gene analysis by next-generation sequencing: a comprehensive genetic diagnosis of Duchenne and Becker muscular dystrophy.

Authors:  Yan Wang; Yao Yang; Jing Liu; Xiao-Chun Chen; Xin Liu; Chun-Zhi Wang; Xi-Yu He
Journal:  Mol Genet Genomics       Date:  2014-04-27       Impact factor: 3.291

8.  Categorization of 77 dystrophin exons into 5 groups by a decision tree using indexes of splicing regulatory factors as decision markers.

Authors:  Rusdy Ghazali Malueka; Yutaka Takaoka; Mariko Yagi; Hiroyuki Awano; Tomoko Lee; Ery Kus Dwianingsih; Atsushi Nishida; Yasuhiro Takeshima; Masafumi Matsuo
Journal:  BMC Genet       Date:  2012-03-31       Impact factor: 2.797

9.  Targeted RNA-Seq profiling of splicing pattern in the DMD gene: exons are mostly constitutively spliced in human skeletal muscle.

Authors:  Anne-Laure Bougé; Eva Murauer; Emmanuelle Beyne; Julie Miro; Jessica Varilh; Magali Taulan; Michel Koenig; Mireille Claustres; Sylvie Tuffery-Giraud
Journal:  Sci Rep       Date:  2017-01-03       Impact factor: 4.379

10.  DMD transcripts in CRL-2061 rhabdomyosarcoma cells show high levels of intron retention by intron-specific PCR amplification.

Authors:  Emma Tabe Eko Niba; Ryo Yamanaka; Abdul Qawee Mahyoob Rani; Hiroyuki Awano; Masaaki Matsumoto; Hisahide Nishio; Masafumi Matsuo
Journal:  Cancer Cell Int       Date:  2017-05-23       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.